Roger Mills

Executive VP, Development, Acadia Pharmaceuticals.

Companies

Addex Therapeutics Ltd.Board member Mar 25, 2026 to now¹
Addex Therapeutics Ltd.CHIEF MEDICAL OFFICER Mar 25, 2026 to now¹
Acadia PharmaceuticalsExecutive VP, Development Jun 30, 2006 to Mar 24, 2015²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Addex Therapeutics Ltd. ADXN785,976 shares³$2.3M at $2.92Sep 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 2, 2026Granted 392,837 shares of Addex Therapeutics Ltd.³
Sep 2, 2026Returned to company 392,837 shares of Addex Therapeutics Ltd.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAddex Therapeutics Ltd., Board member
2
SEC EDGARAcadia Pharmaceuticals, Executive VP, Development
3
SEC EDGARAddex Therapeutics Ltd. shares after the filing of Sep 2, 2026